Cited by 1,251Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Open access

O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., for the Hypertrophic Cardiomyopathy Outcomes Investigators·2014·European Heart Journal

DOI 10.1093/eurheartj/eht439

Open this paper in CoChat — free account Open PDF

Abstract

AIMS: Hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death (SCD) in young adults. Current risk algorithms provide only a crude estimate of risk and fail to account for the different effect size of individual risk factors. The aim of this study was to develop and validate a new SCD risk prediction model that provides individualized risk estimates. METHODS AND RESULTS: The prognostic model was derived from a retrospective, multi-centre longitudinal cohort study. The model was developed from the entire data set using the Cox proportional hazards model and internally validated using bootstrapping. The cohort consisted of 3675 consecutive patients from six centres. During a follow-up period of 24 313 patient-years (median 5.7 years), 198 patients (5%) died suddenly or had an appropriate implantable cardioverter defibrillator (ICD) shock. Of eight pre-specified predictors, age, maximal left ventricular wall thickness, left atrial diameter, left ventricular outflow tract gradient, family history of SCD, non-sustained ventricular tachycardia, and unexplained syncope were associated with SCD/appropriate ICD shock at the 15% significance level. These predictors were included in the final model to estimate individual probabilities of SCD at 5 years. The calibration slope was 0.91 (95% CI: 0.74, 1.08), C-index was 0.70 (95% CI: 0.68, 0.72), and D-statistic was 1.07 (95% CI: 0.81, 1.32). For every 16 ICDs implanted in patients with ≥4% 5-year SCD risk, potentially 1 patient will be saved from SCD at 5 years. A second model with the data set split into independent development and validation cohorts had very similar estimates of coefficients and performance when externally validated. CONCLUSION: This is the first validated SCD risk prediction model for patients with HCM and provides accurate individualized estimates for the probability of SCD using readily collected clinical parameters.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/eurheartj/eht439

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
Self-citation
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259

Show all 50 references

Research works printed but not linked: 1

2012, Circulation: Arrhythmia and Electrophysiology, 6, 443

Sorted by citations

Items 201–300 of 999

Mechanical dispersion and global longitudinal strain by speckle tracking echocardiography: Predictors of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy
Candan, Ö., Geçmen, Ç., Bayam, E. M., Güner, A., Çelık, M., & Doğan, C. (2017) · Echocardiography · doi:10.1111/echo.13547 · Cited by 43
A Simple Community-Based Risk-Prediction Score for Sudden Cardiac Death
Bogle, B. M., Ning, H., Goldberger, J. J., Mehrotra, S., & Lloyd‐Jones, D. M. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.002 · Cited by 44
Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis
Veselka, J., Faber, L., Liebregts, M., Cooper, R. M., Januška, J., Kashtanov, M. G., Dąbrowski, M., Hansen, P. R., Seggewiß, H., Hansvenclová, E., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz110 · Cited by 43
Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy
Kaltenecker, E., Schleihauf, J., Meierhofer, C., Shehu, N., Mkrtchyan, N., Hager, A., Kühn, A., Cleuziou, J., Klingel, K., Seidel, H., et al. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.05.01 · Cited by 43
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.004 · Cited by 42
The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy
Özyılmaz, S., Akgül, Ö., Uyarel, H., Püşüroğlu, H., Gül, M., Satılmışoğlu, M. H., Bolat, İ., Özyılmaz, İ., Uçar, H., Yildirim, A., et al. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2016.09.014 · Cited by 42
Major Clinical Issues in Hypertrophic Cardiomyopathy
Lee, H., Kim, J., Chang, S., Kim, Y.-J., Kim, H., & Lee, S. (2022) · Korean Circulation Journal · doi:10.4070/kcj.2022.0159 · Cited by 44
Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions
Daubert, J., Gadler, F., Mabo, P., & Linde, C. M. (2017) · EP Europace · doi:10.1093/europace/eux131 · Cited by 41
The role of the M-band myomesin proteins in muscle integrity and cardiac disease
Lamber, E. P., Guicheney, P., & Pinotsis, N. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00801-6 · Cited by 43
Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model in Hypertrophic Cardiomyopathy in a Reference Center in South America
Fernández, A., Quiroga, A., Ochoa, J. P., Mysuta, M. A., Casabé, J. H., Biagetti, M. O., Guevara, E., Favaloro, L. E., Fava, A. M., & Galizio, N. O. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.04.021 · Cited by 41
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis
Mascia, G., Crotti, L., Groppelli, A., Canepa, M., Merlo, A. C., Benenati, S., Donna, P. D., Bona, R. D., Soranna, D., Zambon, A., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.03.028 · Cited by 41
Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?
Corrado, D., Link, M. S., & Schwartz, P. J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac298 · Cited by 41
Incidence, Risk Assessment and Prevention of Sudden Cardiac Death in Cardiomyopathies
Polovina, M. M., Tschöpe, C., Rosano, G. M. C., Metra, M., Crea, F., Müllens, W., Bauersachs, J. K., Sliwa, K. S., de Boer, R. A., Farmakis, D. T., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.3076 · Cited by 41
Artificial intelligence in cardiovascular medicine: An updated review of the literature
Zargarzadeh, A., Javanshir, E., Ghaffari, A., Mosharkesh, E., & Anari, B. (2023) · Journal of Cardiovascular and Thoracic Research · doi:10.34172/jcvtr.2023.33031 · Cited by 41
Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography
Turvey-Haigh, L., Augustine, D. X., Robinson, S., Oxborough, D., Stout, M., Smith, N., Harkness, A., Williams, L. K., Steeds, R. P., & Bradlow, W. M. (2021) · Echo Research and Practice · doi:10.1530/erp-20-0042 · Cited by 40
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy
Captur, G., Manisty, C., Raman, B., Marchi, A. G., Wong, T. C., Ariga, R., Bhuva, A., Ormondroyd, E., Lobascio, I., Camaioni, C., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.03.032 · Cited by 40
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives
Zampieri, M., Berteotti, M., Ferrantini, C., Tassetti, L., Gabriele, M., Tomberli, B., Castelli, G., Cappelli, F., Stefàno, P., Marchionni, N., et al. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00523-0 · Cited by 41
Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy
Yang, F., Wang, L., Wang, J., Pu, L., Xu, Y., Li, W., Wan, K., Yang, D., Sun, J., Han, Y., et al. (2021) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-021-00735-2 · Cited by 40
Machine Learning in Hypertrophic Cardiomyopathy
Zhao, K., Zhu, Y., Chen, X., Yang, S., Yan, W. P., Yang, K., Song, Y., Cui, C., Xu, X., Zhu, Q., et al. (2024) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2024.04.013 · Cited by 39
Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long‐Term Follow‐Up Study Based on the Euro‐Alcohol Septal Ablation Registry
Veselka, J., Faber, L., Liebregts, M., Cooper, R. M., Januška, J., Krejčí, J., Bartel, T., Dąbrowski, M., Hansen, P. R., Almaas, V. M., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005735 · Cited by 39
Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy
Bottillo, I., D’Angelantonio, D., Caputo, V., Paiardini, A., Lipari, M., Bernardo, C. D., Giannarelli, D., Pizzuti, A., Majore, S., Castori, M., et al. (2015) · Gene · doi:10.1016/j.gene.2015.11.048 · Cited by 37
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants
Rowin, E. J., Burrows, A., Madias, C. A., Estes, N. A. M., Link, M. S., Maron, M. S., & Maron, B. J. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.008123 · Cited by 37
Obstruction after alcohol septal ablation is associated with cardiovascular mortality events
Veselka, J., Tomašov, P., Januška, J., Krejčí, J., & Adlová, R. (2016) · Heart · doi:10.1136/heartjnl-2016-309699 · Cited by 36
QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy
Patel, S. I., Ackerman, M. J., Shamoun, F. E., Geske, J. B., Ommen, S. R., Love, W. T., Cha, S. S., Bos, J. M., & Lester, S. J. (2018) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1440905 · Cited by 36
Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing
Moon, S., Liu, S., Scott, C. G., Samudrala, S. K., Abidian, M. M., Geske, J. B., Noseworthy, P. A., Shellum, J. L., Chaudhry, R., Ommen, S. R., et al. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.05.008 · Cited by 35
ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy
Trivedi, A. D., & Knight, B. P. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:30:2 · Cited by 34
Monocyte to High-Density Lipoprotein Cholesterol Ratio Predicts Adverse Cardiac Events in Patients with Hypertrophic Cardiomyopathy
Ekizler, F. A., Çay, S., Açar, B., Tak, B. T., Kafes, H., Özeke, Ö., Çetin, E. H. Ö., Özcan, F., Topaloğlu, S., Tüfekçioğlu, O., et al. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0089 · Cited by 34
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study
Nazer, B., Dale, Z., Carrassa, G., Reza, N., Üstünkaya, T., Papoutsidakis, N., Gray, A. R., Howell, S. J., Elman, M., Pieragnoli, P., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.02.008 · Cited by 34
The Public Health Burden of Cardiomyopathies: Insights from a Nationwide Inpatient Study
Lannou, S., Mansencal, N., Couchoud, C., Lassalle, M., Dubourg, O., Stengel, B., Jacquelinet, C., & Charron, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040920 · Cited by 34
European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Aktaa, S., Tzeis, S. E., Gale, C. P., Ackerman, M. J., Arbelo, E., Behr, E. R., Crotti, L., d’Ávila, A., de Chillou, C., Deneke, T., et al. (2022) · EP Europace · doi:10.1093/europace/euac114 · Cited by 34
Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy
Weissler‐Snir, A., Chan, R. H. M., Adler, A., Care, M. E., Chauhan, V. S., Gollob, M. H., Ziv‐Baran, T., Fourey, D., Hindieh, W., Rakowski, H., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.043 · Cited by 34
Mitral valve repair or replacement in hypertrophic obstructive cardiomyopathy: a prospective randomized study†
Bogachev-Prokophiev, A. V., Afanasyev, A. V., Иванович, Ж. С., Фоменко, М. С., Махарамович, Ш. Р., Kretov, E., & Karaskov, A. M. (2017) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivx152 · Cited by 34
The Female Athlete’s Heart: Overview and Management of Cardiovascular Diseases
Castelletti, S., & Gati, S. (2021) · European Cardiology Review · doi:10.15420/ecr.2021.29 · Cited by 35
Penetrance of Hypertrophic Cardiomyopathy in Children Who Are Mutation Positive
Vermeer, A. M. C., Clur, S. B., Blom, N. A., Wilde, A. A. M., & Christiaans, I. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.03.033 · Cited by 33
Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications
Wang, N., Xie, A., Tjahjono, R., Tian, D. H., Phan, S., Yan, T. D., Bajona, P., & Phan, K. H. (2017) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2017.07.05 · Cited by 33
Application of machine learning in the diagnosis of axial spondyloarthritis
Walsh, J. A., Rozycki, M., Yi, E., & Park, Y. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000612 · Cited by 33
Prevalence and Prognostic Implications of Right Ventricular Dysfunction in Patients With Hypertrophic Cardiomyopathy
Hiemstra, Y. L., Debonnaire, P., Bootsma, M., Schalij, M. J., Bax, J. J., Delgado, V., & Marsan, N. A. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.05.021 · Cited by 33
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy
Rowin, E. J., Sridharan, A., Madias, C. A., Firely, C., Koethe, B. C., Link, M. S., Maron, M. S., & Maron, B. J. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.04.042 · Cited by 33
Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy
Essayagh, B. A., Resseguier, N., Michel, N., Casalta, A., Renard, S., Donghi, V., Carbone, A., Piazzai, C., Ambrosi, P., Lévy, F., et al. (2020) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2020.06.004 · Cited by 33
N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy
Wu, G., Liu, J., Wang, S., Yu, S., Zhang, C., Wang, D., Zhang, M., Yang, Y., Kang, L., Zhao, S., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-317701 · Cited by 34
Exercise and Inherited Arrhythmias
Cheung, C. C., Laksman, Z., Mellor, G., Sanatani, S., & Krahn, A. D. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.01.007 · Cited by 33
Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation
Dusi, V., Dagradi, F., Spazzolini, C., Crotti, L., Cerea, P., Giovenzana, F. L. F., Musu, G., Pedrazzini, M., Torchio, M., & Schwartz, P. J. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae289 · Cited by 32
An evaluation of sample size requirements for developing risk prediction models with binary outcomes
Pavlou, M., Ambler, G., Chen, Q., Seaman, S. R., White, I. R., & Omar, R. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02268-5 · Cited by 32
Self-citation
Late gadolinium enhancement imaging and sudden cardiac death
Prasad, S. K., Akbari, T., Bishop, M. J., Halliday, B. P., Leyva, F., & Marchlinski, F. E. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf464 · Cited by 34
Hypertrophic Obstructive Cardiomyopathy
Batzner, A., Schäfers, H., Borisov, K. V., & Seggewiß, H. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0047 · Cited by 33
Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring
Ginder, C. R., Li, J., Halperin, J. L., Akar, J. G., Martin, D. T., Chattopadhyay, I., & Upadhyay, G. A. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.12.024 · Cited by 32
Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation
Minami, Y., Haruki, S., Yashiro, B., Suzuki, T., Ashihara, K., & Hagiwara, N. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.01.006 · Cited by 32
A systematic review and meta-analysis of left atrial strain in hypertrophic cardiomyopathy and its prognostic utility
Hussain, K., Nso, N., Tsourdinis, G. E., Haider, S., Mian, R., Sanagala, T., Erwin, J. P., & Pursnani, A. K. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102146 · Cited by 31
Genome-wide association analysis of left ventricular imaging-derived phenotypes identifies 72 risk loci and yields genetic insights into hypertrophic cardiomyopathy
Ning, C., Fan, L., Jin, M., Wang, W., Hu, Z., Cai, Y., Chen, L., Lu, Z., Zhang, M., Chen, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43771-5 · Cited by 31
Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy
O’Mahony, C., Jichi, F., Monserrat, L., Ortiz-Genga, M., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.003818 · Cited by 31
Self-citation
High Signal Intensity on T2-Weighted Cardiovascular Magnetic Resonance Imaging Predicts Life-Threatening Arrhythmic Events in Hypertrophic Cardiomyopathy Patients
Hen, Y., Takara, A., Iguchi, N., Utanohara, Y., Teraoka, K., Takada, K., Machida, H., Takamisawa, I., Takayama, M., & Yoshikawa, T. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-1235 · Cited by 31
Mechanisms of sudden cardiac death
McElwee, S., Velasco, A., & Doppalapudi, H. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0600-6 · Cited by 30
A Computer Vision Pipeline for Automated Determination of Cardiac Structure and Function and Detection of Disease by Two-Dimensional EchocardiographyPreprint
Zhang, J., Gajjala, S., Agrawal, P., Tison, G. H., Hallock, L. A., Beussink‐Nelson, L., Fan, E., Aras, M. A., Jordan, C., Fleischmann, K. E., et al. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1706.07342 · Cited by 31
Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator
Salas, A. R., García‐Pinilla, J. M., Cabrera‐Bueno, F., Fernández-Pastor, J., Peña-Hernández, J., Medina-Palomo, C., Barrera-Cordero, A., de Teresa, E., & Alzueta, J. (2015) · EP Europace · doi:10.1093/europace/euv079 · Cited by 30
Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy
Spinner, J. A., Noel, C. V., Denfield, S. W., Krishnamurthy, R., Jeewa, A., Dreyer, W. J., & Maskatia, S. A. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.01.032 · Cited by 30
Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy
Thavikulwat, A. C., Tomson, T. T., Knight, B. P., Bonow, R. O., & Choudhury, L. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13005 · Cited by 30
New Developments in Hypertrophic Cardiomyopathy
Cooper, R. M., Raphael, C. E., Liebregts, M., Anavekar, N. S., & Veselka, J. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.07.007 · Cited by 30
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal
Pelliccia, F., Niccoli, G., Gragnano, F., Limongelli, G., Moscarella, E., Andò, G., Esposito, A., Stabile, E., Ussia, G. P., Tarantini, G., et al. (2019) · EuroIntervention · doi:10.4244/eij-d-18-00959 · Cited by 30
Self-citation
Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning
Kochav, S. M., Raita, Y., Fifer, M. A., Takayama, H., Ginns, J. N., Maurer, M. S., Reilly, M. P., Hasegawa, K., & Shimada, Y. J. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.11.003 · Cited by 30
Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other Inherited Cardiovascular Diseases
Semsarian, C., Gray, B. R., Haugaa, K. H., Lampert, R. J., Sharma, S., & Kovacic, J. C. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.07.013 · Cited by 30
High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy
Gommans, D. H. F., Cramer, G. E., Bakker, J., Dieker, H.-J., Michels, M., Fouraux, M. A., Marcelis, C., Verheugt, F. W. A., Timmermans, J., Brouwer, M. A., et al. (2017) · International journal of cardiac imaging · doi:10.1007/s10554-017-1252-6 · Cited by 29
Updating the Risk Stratification for Sudden Cardiac Death in Cardiomyopathies: The Evolving Role of Cardiac Magnetic Resonance Imaging. An Approach for the Electrophysiologist
Kariki, O. K., Antoniou, C. K., Mavrogeni, S. I., & Gatzoulis, K. A. (2020) · Diagnostics · doi:10.3390/diagnostics10080541 · Cited by 29
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy—Are there predictors of appropriate therapy?
Weissler‐Snir, A., Dorian, P., Rakowski, H., Care, M. E., & SPEARS, D. A. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.08.009 · Cited by 29
Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy
Dohy, Z., Szabó, L. E., Tóth, A., Czimbalmos, C., Horvath, R., Horváth, V. J., Suhai, F. I., Gellér, L., Merkely, B. P., & Vágó, H. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02165-8 · Cited by 29
Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
Chen, L., Fu, G., & Jiang, C. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2235564 · Cited by 28
Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy
Gatzoulis, K. A., Georgopoulos, S., Antoniou, C. K., Anastasakis, A., Dilaveris, P., Αρσένος, Π., Sideris, S. K., Tsiachris, D., Archontakis, S., Sotiropoulos, E., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.033 · Cited by 30
Self-citation
Sudden Cardiac Death and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Moore, B. M., Semsarian, C., Chan, K. H., & Sy, R. W. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.07.019 · Cited by 29
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy
Chan, R. H. M., van der Wal, L., Liberato, G., Rowin, E. J., Soslow, J. H., Maskatia, S. A., Chan, S. S., Shah, A. M., Fogel, M. A., Hernandez, L., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.2824 · Cited by 28
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Priori, S. G., Blomström‐Lundqvist, C., Mazzanti, A., Blom, N. A., Borggrefe, M., Camm, A. J., Elliot, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.01.001 · Cited by 138
Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy
Rigopoulos, A. G., Daci, S., Pfeiffer, B., Papadopoulou, K., Neugebauer, A., & Seggewiß, H. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1005-x · Cited by 28
Cardiomiopatia Hipertrófica – Revisão
Bazan, S. G. Z., de Oliveira, G. O., da Silveira, C. F. D. S. M. P., Reis, F. M., Malagutte, K. N. D. S., Tinasi, L. S. N., Bazán, R., Hueb, J. C., & Okoshi, K. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190802 · Cited by 31
Emerging Medical Treatment for Hypertrophic Cardiomyopathy
Argirò, A., Zampieri, M., Berteotti, M., Marchi, A. G., Tassetti, L., Zocchi, C., Iannone, L., Bacchi, B., Cappelli, F., Stefàno, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050951 · Cited by 31
Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy
Zegkos, T., Tziomalos, G., Parcharidou, D. G., Ntelios, D., Papanastasiou, C. A., Karagiannidis, E., Gossios, T. D., Rouskas, P., Katranas, S., Paraskevaidis, S., et al. (2021) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2021.06.005 · Cited by 28
Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Konno, T., Nagata, Y., Teramoto, R., Fujino, N., Nomura, A., Tada, H., Sakata, K., Furusho, H., Takamura, M., Nakamura, H., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.11.015 · Cited by 28
Guía ESC 2020 sobre cardiología del deporte y el ejercicio en pacientes con enfermedad cardiovascular
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.11.026 · Cited by 35
Deep Learning Analysis of Echocardiographic Images to Predict Positive Genotype in Patients With Hypertrophic Cardiomyopathy
Morita, S. X., Kusunose, K., Haga, A., Sata, M., Hasegawa, K., Raita, Y., Reilly, M. P., Fifer, M. A., Maurer, M. S., & Shimada, Y. J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.669860 · Cited by 27
Blood-Based Biomarkers for the Prediction of Hypertrophic Cardiomyopathy Prognosis: A Systematic Review and Meta-Analysis
Jansen, M., Algül, S., Bosman, L. P., Michels, M., van der Velden, J., de Boer, R. A., van Tintelen, J. P., Asselbergs, F. W., & Baas, A. F. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14073 · Cited by 27
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
Shen, H. M., Dong, S.-Y., Ren, M.-S., & Wang, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.949294 · Cited by 27
Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy
Jalanko, M., Tarkiainen, M., Sipola, P., Jääskeläinen, P., Lauerma, K., Laine, M., Nieminen, M. S., Laakso, M., Heliö, T. M., & Kuusisto, J. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1186826 · Cited by 27
Role of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Systematic Review and Updated Meta-Analysis of Risk Markers for Sudden Death
Bittencourt, M. I., Cader, S. A., Araújo, D. V., Salles, A. L. F., Albuquerque, F. N., Spineti, P. P. D. M., de Albuquerque, D. C., & Mourilhe‐Rocha, R. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190045 · Cited by 27
Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024
Fernandes, F., Simões, M. V., Correia, E. D. B., Marcondes‐Braga, F. G., Coelho‐Filho, O. R., Mesquita, C. T., Mathias, W., Antunes, M. D. O., Arteaga-Fernández, E., Rochitte, C. E., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240415i · Cited by 26
Long-Term Outcomes for Different Surgical Strategies to Treat Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
Collis, R., Watkinson, O. T., O’Mahony, C., Guttmann, O. P., Pantazis, A. A., Tome, M., Tsang, V. T., Chandrasekaran, V., McGregor, C. G. A., & Elliot, P. M. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1038 · Cited by 26
Self-citation
A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk)
Kayvanpour, E., Sammani, A., Sedaghat‐Hamedani, F., Lehmann, D. H., Broezel, A., Koelemen, J., Chmielewski, P., Curjol, A., Socié, P., Miersch, T., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.07.002 · Cited by 26
Arrhythmic syncope: From diagnosis to management
Pascual, J. F., Jordán-Marchite, P., Silva, J. R., & Rivas‐Gándara, N. (2023) · World Journal of Cardiology · doi:10.4330/wjc.v15.i4.119 · Cited by 29
Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
Hindieh, W., Chan, R. H. M., & Rakowski, H. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0897-z · Cited by 26
Current management of hypertrophic cardiomyopathy
Sikand, N., Stendahl, J., Sen, S., Lampert, R., & Day, S. (2025) · BMJ · doi:10.1136/bmj-2023-077274 · Cited by 26
Machine Learning-Based Discrimination of Cardiovascular Outcomes in Patients With Hypertrophic Cardiomyopathy
Rhee, T., Ko, Y.-K., Kim, H., Lee, S.-B., Kim, B., Choi, H., Hwang, I., Park, J., Yoon, Y. E., Kim, Y.-J., et al. (2024) · JACC Asia · doi:10.1016/j.jacasi.2023.12.001 · Cited by 24
The Role of Stem Cells in the Treatment of Cardiovascular Diseases
Bakinowska, E., Kiełbowski, K., Boboryko, D., Bratborska, A. W., Olejnik-Wojciechowska, J., Rusiński, M., & Pawlik, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073901 · Cited by 26
Hypertrophic cardiomyopathy
Argirò, A., Parikh, V. N., Jurcut, R. O., Finocchiaro, G., Kaski, J. P., ADLER, E. D., & Olivotto, I. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00643-0 · Cited by 29
Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk‐score and HCMRisk‐Kids score
Östman‐Smith, I., Sjöberg, G., Dahlqvist, J. A., Larsson, P., & Fernlund, E. (2021) · Acta Paediatrica · doi:10.1111/apa.16045 · Cited by 25
Sport practice in hypertrophic cardiomyopathy: running to stand still?
Mascia, G., Olivotto, I., Brugada, J., Arbelo, E., Donna, P. D., Bona, R. D., Canepa, M., & Porto, I. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.10.013 · Cited by 25
Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know
Gati, S., & Sharma, S. (2022) · Heart · doi:10.1136/heartjnl-2021-319861 · Cited by 25
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management
Brignole, M., Cecchi, F., Anastasakis, A., Crotti, L., Deharo, J., Elliot, P. M., Fedorowski, A., Kaski, J. P., Limongelli, G., Maron, M. S., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.10.153 · Cited by 25
Self-citation
Diretriz Brasileira de Dispositivos Cardíacos Eletrônicos Implantáveis – 2023
Teixeira, R. A., Fagundes, A. A., Baggio, J. M., de Oliveira, J. C., Medeiros, P. D. T. J., Valdigem, B. P., Teno, L. A. C., Silva, R. T., de Melo, C. S., Elías, J., et al. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220892 · Cited by 53
Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography
Joy, G., Lopes, L. R., Webber, M. R., Ardissino, A. M., WILSON, J. G., Chan, F., Pierce, I., Hughes, R. K., Moschonas, K., Shiwani, H., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.01.006 · Cited by 25
Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
Doesch, C., Tülümen, E., Akın, İ., Rudic, B., Kuschyk, J., El‐Battrawy, I., Becher, T., Budjan, J., Smakic, A., Schoenberg, S. O., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06533-0 · Cited by 24
Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram
Togo, S., Sugiura, Y., Suzuki, S., Ohno, K., Akita, K., Suwa, K., Shibata, S., Kimura, M., & Maekawa, Y. (2023) · Open Heart · doi:10.1136/openhrt-2023-002414 · Cited by 24
Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement
Mathijssen, H., Bawaskar, P. H., Rochlani, Y. M., Georgy, I., Athwal, P. S. S., Guo, Y. Y., Pollmann, D., Markowitz, J., von Wald, L. N., Roukoz, H., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf338 · Cited by 24
Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy
Goff, Z. D., & Calkins, H. G. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.04.001 · Cited by 24
Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy
Yin, Y.-W., Hu, W., Zhang, L., Wu, D., Yang, C., & Ye, X. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02430-w · Cited by 24

Authors: O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M., & for the Hypertrophic Cardiomyopathy Outcomes Investigators
Affiliations: University College London (GB)
National and Kapodistrian University of Athens (GR)
University of Bologna (IT)
Hospital Universitario Virgen de la Arrixaca (ES)
University of Campania "Luigi Vanvitelli" (IT)
University College Hospital at Westmoreland Street (GB)
ORCID: Pavlou, M.
Monserrat, L.
Rapezzi, C.
Biagini, E.
Gimeno, J. R.
Limongelli, G.
McKenna, W. J.
Omar, R. Z.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2013-10-14
Volume: 35
Issue: 30
Pages: 2010-2020
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/eht439
OpenAlex: W2119361626
Cited by: 1,251
References: 50
Citations by year: 2026: 107 · 2025: 124 · 2024: 115 · 2023: 120 · 2022: 99 · 2021: 125 · 2020: 116 · 2019: 87 · 2018: 81 · 2017: 100 · 2016: 67 · 2015: 76 · 2014: 31 · 2013: 2
FWCI: 39.92
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Hispana (submittedVersion)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Funders: National Institute for Health and Care Research (NF-SI-0509-10230)
Università di Bologna
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, sudden cardiac death, risk prediction model, individualized risk estimation, implantable cardioverter-defibrillator, left ventricular wall thickness, left ventricular outflow tract gradient, family history of sudden cardiac death, non-sustained ventricular tachycardia, unexplained syncope, left atrial diameter, model validation
MeSH terms: Adult, Cardiomyopathy, Hypertrophic, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Reproducibility of Results, Proportional Hazards Models, Death, Sudden, Cardiac, Sample Size, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks